img

Global Fluoxetine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Fluoxetine Market Insights, Forecast to 2034

Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.
Global Fluoxetine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Fluoxetine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Fluoxetine key manufacturers include Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company and Aurobindo Pharma, etc. Teva, Sun Pharmaceutical, Sandoz are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Fluoxetine were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Fluoxetine market and estimated to attract more attentions from industry insiders and investors.
Fluoxetine can be divided into Tablets, Capsules and Oral Solution,, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Fluoxetine is widely used in various fields, such as Depression, Obsessive–Compulsive Disorder, Panic Disorder and Bulimia Nervosa, etc. Depression provides greatest supports to the Fluoxetine industry development. In 2022, global % sales of Fluoxetine went into Depression filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Fluoxetine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Fluoxetine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
Segment by Type
Tablets
Capsules
Oral Solution

Segment by Application


Depression
Obsessive–Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Fluoxetine plant distribution, commercial date of Fluoxetine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Fluoxetine introduction, etc. Fluoxetine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Fluoxetine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Fluoxetine Product Introduction
1.2 Market by Type
1.2.1 Global Fluoxetine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Oral Solution
1.3 Market by Application
1.3.1 Global Fluoxetine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Depression
1.3.3 Obsessive–Compulsive Disorder
1.3.4 Panic Disorder
1.3.5 Bulimia Nervosa
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fluoxetine Sales Estimates and Forecasts 2018-2029
2.2 Global Fluoxetine Revenue by Region
2.2.1 Global Fluoxetine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Fluoxetine Revenue by Region (2018-2024)
2.2.3 Global Fluoxetine Revenue by Region (2024-2029)
2.2.4 Global Fluoxetine Revenue Market Share by Region (2018-2029)
2.3 Global Fluoxetine Sales Estimates and Forecasts 2018-2029
2.4 Global Fluoxetine Sales by Region
2.4.1 Global Fluoxetine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Fluoxetine Sales by Region (2018-2024)
2.4.3 Global Fluoxetine Sales by Region (2024-2029)
2.4.4 Global Fluoxetine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Fluoxetine Sales by Manufacturers
3.1.1 Global Fluoxetine Sales by Manufacturers (2018-2024)
3.1.2 Global Fluoxetine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fluoxetine in 2022
3.2 Global Fluoxetine Revenue by Manufacturers
3.2.1 Global Fluoxetine Revenue by Manufacturers (2018-2024)
3.2.2 Global Fluoxetine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Fluoxetine Revenue in 2022
3.3 Global Key Players of Fluoxetine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Fluoxetine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Fluoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Fluoxetine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Fluoxetine, Product Offered and Application
3.8 Global Key Manufacturers of Fluoxetine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fluoxetine Sales by Type
4.1.1 Global Fluoxetine Historical Sales by Type (2018-2024)
4.1.2 Global Fluoxetine Forecasted Sales by Type (2024-2029)
4.1.3 Global Fluoxetine Sales Market Share by Type (2018-2029)
4.2 Global Fluoxetine Revenue by Type
4.2.1 Global Fluoxetine Historical Revenue by Type (2018-2024)
4.2.2 Global Fluoxetine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Fluoxetine Revenue Market Share by Type (2018-2029)
4.3 Global Fluoxetine Price by Type
4.3.1 Global Fluoxetine Price by Type (2018-2024)
4.3.2 Global Fluoxetine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Fluoxetine Sales by Application
5.1.1 Global Fluoxetine Historical Sales by Application (2018-2024)
5.1.2 Global Fluoxetine Forecasted Sales by Application (2024-2029)
5.1.3 Global Fluoxetine Sales Market Share by Application (2018-2029)
5.2 Global Fluoxetine Revenue by Application
5.2.1 Global Fluoxetine Historical Revenue by Application (2018-2024)
5.2.2 Global Fluoxetine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Fluoxetine Revenue Market Share by Application (2018-2029)
5.3 Global Fluoxetine Price by Application
5.3.1 Global Fluoxetine Price by Application (2018-2024)
5.3.2 Global Fluoxetine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Fluoxetine Market Size by Type
6.1.1 US & Canada Fluoxetine Sales by Type (2018-2029)
6.1.2 US & Canada Fluoxetine Revenue by Type (2018-2029)
6.2 US & Canada Fluoxetine Market Size by Application
6.2.1 US & Canada Fluoxetine Sales by Application (2018-2029)
6.2.2 US & Canada Fluoxetine Revenue by Application (2018-2029)
6.3 US & Canada Fluoxetine Market Size by Country
6.3.1 US & Canada Fluoxetine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Fluoxetine Sales by Country (2018-2029)
6.3.3 US & Canada Fluoxetine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Fluoxetine Market Size by Type
7.1.1 Europe Fluoxetine Sales by Type (2018-2029)
7.1.2 Europe Fluoxetine Revenue by Type (2018-2029)
7.2 Europe Fluoxetine Market Size by Application
7.2.1 Europe Fluoxetine Sales by Application (2018-2029)
7.2.2 Europe Fluoxetine Revenue by Application (2018-2029)
7.3 Europe Fluoxetine Market Size by Country
7.3.1 Europe Fluoxetine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Fluoxetine Sales by Country (2018-2029)
7.3.3 Europe Fluoxetine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Fluoxetine Market Size
8.1.1 China Fluoxetine Sales (2018-2029)
8.1.2 China Fluoxetine Revenue (2018-2029)
8.2 China Fluoxetine Market Size by Application
8.2.1 China Fluoxetine Sales by Application (2018-2029)
8.2.2 China Fluoxetine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Fluoxetine Market Size by Type
9.1.1 Asia Fluoxetine Sales by Type (2018-2029)
9.1.2 Asia Fluoxetine Revenue by Type (2018-2029)
9.2 Asia Fluoxetine Market Size by Application
9.2.1 Asia Fluoxetine Sales by Application (2018-2029)
9.2.2 Asia Fluoxetine Revenue by Application (2018-2029)
9.3 Asia Fluoxetine Sales by Region
9.3.1 Asia Fluoxetine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Fluoxetine Revenue by Region (2018-2029)
9.3.3 Asia Fluoxetine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Fluoxetine Market Size by Type
10.1.1 Middle East, Africa and Latin America Fluoxetine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Fluoxetine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Fluoxetine Market Size by Application
10.2.1 Middle East, Africa and Latin America Fluoxetine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Fluoxetine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Fluoxetine Sales by Country
10.3.1 Middle East, Africa and Latin America Fluoxetine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Fluoxetine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Fluoxetine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Overview
11.1.3 Teva Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Teva Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Recent Developments
11.3 Sandoz
11.3.1 Sandoz Company Information
11.3.2 Sandoz Overview
11.3.3 Sandoz Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sandoz Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sandoz Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Wockhardt
11.5.1 Wockhardt Company Information
11.5.2 Wockhardt Overview
11.5.3 Wockhardt Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Wockhardt Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wockhardt Recent Developments
11.6 Dr.Reddy's Laboratories
11.6.1 Dr.Reddy's Laboratories Company Information
11.6.2 Dr.Reddy's Laboratories Overview
11.6.3 Dr.Reddy's Laboratories Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Dr.Reddy's Laboratories Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr.Reddy's Laboratories Recent Developments
11.7 Pharmaceutical Associates Inc.
11.7.1 Pharmaceutical Associates Inc. Company Information
11.7.2 Pharmaceutical Associates Inc. Overview
11.7.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Pharmaceutical Associates Inc. Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pharmaceutical Associates Inc. Recent Developments
11.8 Lannett Company
11.8.1 Lannett Company Company Information
11.8.2 Lannett Company Overview
11.8.3 Lannett Company Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Lannett Company Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lannett Company Recent Developments
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Information
11.9.2 Aurobindo Pharma Overview
11.9.3 Aurobindo Pharma Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Aurobindo Pharma Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aurobindo Pharma Recent Developments
11.10 Alembic Pharmaceuticals
11.10.1 Alembic Pharmaceuticals Company Information
11.10.2 Alembic Pharmaceuticals Overview
11.10.3 Alembic Pharmaceuticals Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Alembic Pharmaceuticals Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Alembic Pharmaceuticals Recent Developments
11.11 Alvogen
11.11.1 Alvogen Company Information
11.11.2 Alvogen Overview
11.11.3 Alvogen Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Alvogen Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Alvogen Recent Developments
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Company Information
11.12.2 Torrent Pharmaceuticals Overview
11.12.3 Torrent Pharmaceuticals Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Torrent Pharmaceuticals Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Torrent Pharmaceuticals Recent Developments
11.13 Suzhou YUSHI Pharmaceutical
11.13.1 Suzhou YUSHI Pharmaceutical Company Information
11.13.2 Suzhou YUSHI Pharmaceutical Overview
11.13.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Suzhou YUSHI Pharmaceutical Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Suzhou YUSHI Pharmaceutical Recent Developments
11.14 Changzhou Siyao Pharmaceutical
11.14.1 Changzhou Siyao Pharmaceutical Company Information
11.14.2 Changzhou Siyao Pharmaceutical Overview
11.14.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Changzhou Siyao Pharmaceutical Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Changzhou Siyao Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fluoxetine Industry Chain Analysis
12.2 Fluoxetine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fluoxetine Production Mode & Process
12.4 Fluoxetine Sales and Marketing
12.4.1 Fluoxetine Sales Channels
12.4.2 Fluoxetine Distributors
12.5 Fluoxetine Customers
13 Market Dynamics
13.1 Fluoxetine Industry Trends
13.2 Fluoxetine Market Drivers
13.3 Fluoxetine Market Challenges
13.4 Fluoxetine Market Restraints
14 Key Findings in The Global Fluoxetine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Fluoxetine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsules
Table 4. Major Manufacturers of Oral Solution
Table 5. Global Fluoxetine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Fluoxetine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Fluoxetine Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Fluoxetine Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Fluoxetine Revenue Market Share by Region (2018-2024)
Table 10. Global Fluoxetine Revenue Market Share by Region (2024-2029)
Table 11. Global Fluoxetine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Fluoxetine Sales by Region (2018-2024) & (K Units)
Table 13. Global Fluoxetine Sales by Region (2024-2029) & (K Units)
Table 14. Global Fluoxetine Sales Market Share by Region (2018-2024)
Table 15. Global Fluoxetine Sales Market Share by Region (2024-2029)
Table 16. Global Fluoxetine Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Fluoxetine Sales Share by Manufacturers (2018-2024)
Table 18. Global Fluoxetine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Fluoxetine Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Fluoxetine, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Fluoxetine Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Fluoxetine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Fluoxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluoxetine as of 2022)
Table 24. Global Key Manufacturers of Fluoxetine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Fluoxetine, Product Offered and Application
Table 26. Global Key Manufacturers of Fluoxetine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Fluoxetine Sales by Type (2018-2024) & (K Units)
Table 29. Global Fluoxetine Sales by Type (2024-2029) & (K Units)
Table 30. Global Fluoxetine Sales Share by Type (2018-2024)
Table 31. Global Fluoxetine Sales Share by Type (2024-2029)
Table 32. Global Fluoxetine Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Fluoxetine Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Fluoxetine Revenue Share by Type (2018-2024)
Table 35. Global Fluoxetine Revenue Share by Type (2024-2029)
Table 36. Fluoxetine Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Fluoxetine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Fluoxetine Sales by Application (2018-2024) & (K Units)
Table 39. Global Fluoxetine Sales by Application (2024-2029) & (K Units)
Table 40. Global Fluoxetine Sales Share by Application (2018-2024)
Table 41. Global Fluoxetine Sales Share by Application (2024-2029)
Table 42. Global Fluoxetine Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Fluoxetine Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Fluoxetine Revenue Share by Application (2018-2024)
Table 45. Global Fluoxetine Revenue Share by Application (2024-2029)
Table 46. Fluoxetine Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Fluoxetine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Fluoxetine Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Fluoxetine Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Fluoxetine Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Fluoxetine Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Fluoxetine Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Fluoxetine Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Fluoxetine Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Fluoxetine Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Fluoxetine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Fluoxetine Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Fluoxetine Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Fluoxetine Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Fluoxetine Sales by Country (2024-2029) & (K Units)
Table 61. Europe Fluoxetine Sales by Type (2018-2024) & (K Units)
Table 62. Europe Fluoxetine Sales by Type (2024-2029) & (K Units)
Table 63. Europe Fluoxetine Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Fluoxetine Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Fluoxetine Sales by Application (2018-2024) & (K Units)
Table 66. Europe Fluoxetine Sales by Application (2024-2029) & (K Units)
Table 67. Europe Fluoxetine Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Fluoxetine Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Fluoxetine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Fluoxetine Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Fluoxetine Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Fluoxetine Sales by Country (2018-2024) & (K Units)
Table 73. Europe Fluoxetine Sales by Country (2024-2029) & (K Units)
Table 74. China Fluoxetine Sales by Type (2018-2024) & (K Units)
Table 75. China Fluoxetine Sales by Type (2024-2029) & (K Units)
Table 76. China Fluoxetine Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Fluoxetine Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Fluoxetine Sales by Application (2018-2024) & (K Units)
Table 79. China Fluoxetine Sales by Application (2024-2029) & (K Units)
Table 80. China Fluoxetine Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Fluoxetine Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Fluoxetine Sales by Type (2018-2024) & (K Units)
Table 83. Asia Fluoxetine Sales by Type (2024-2029) & (K Units)
Table 84. Asia Fluoxetine Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Fluoxetine Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Fluoxetine Sales by Application (2018-2024) & (K Units)
Table 87. Asia Fluoxetine Sales by Application (2024-2029) & (K Units)
Table 88. Asia Fluoxetine Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Fluoxetine Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Fluoxetine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Fluoxetine Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Fluoxetine Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Fluoxetine Sales by Region (2018-2024) & (K Units)
Table 94. Asia Fluoxetine Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Fluoxetine Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Fluoxetine Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Fluoxetine Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Fluoxetine Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Fluoxetine Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Fluoxetine Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Fluoxetine Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Fluoxetine Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Fluoxetine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Fluoxetine Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Fluoxetine Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Fluoxetine Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Fluoxetine Sales by Country (2024-2029) & (K Units)
Table 108. Teva Company Information
Table 109. Teva Description and Major Businesses
Table 110. Teva Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Teva Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Teva Recent Developments
Table 113. Sun Pharmaceutical Company Information
Table 114. Sun Pharmaceutical Description and Major Businesses
Table 115. Sun Pharmaceutical Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Sun Pharmaceutical Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sun Pharmaceutical Recent Developments
Table 118. Sandoz Company Information
Table 119. Sandoz Description and Major Businesses
Table 120. Sandoz Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Sandoz Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Sandoz Recent Developments
Table 123. Mylan Company Information
Table 124. Mylan Description and Major Businesses
Table 125. Mylan Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Mylan Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Mylan Recent Developments
Table 128. Wockhardt Company Information
Table 129. Wockhardt Description and Major Businesses
Table 130. Wockhardt Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Wockhardt Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Wockhardt Recent Developments
Table 133. Dr.Reddy's Laboratories Company Information
Table 134. Dr.Reddy's Laboratories Description and Major Businesses
Table 135. Dr.Reddy's Laboratories Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Dr.Reddy's Laboratories Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Dr.Reddy's Laboratories Recent Developments
Table 138. Pharmaceutical Associates Inc. Company Information
Table 139. Pharmaceutical Associates Inc. Description and Major Businesses
Table 140. Pharmaceutical Associates Inc. Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Pharmaceutical Associates Inc. Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Pharmaceutical Associates Inc. Recent Developments
Table 143. Lannett Company Company Information
Table 144. Lannett Company Description and Major Businesses
Table 145. Lannett Company Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Lannett Company Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Lannett Company Recent Developments
Table 148. Aurobindo Pharma Company Information
Table 149. Aurobindo Pharma Description and Major Businesses
Table 150. Aurobindo Pharma Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Aurobindo Pharma Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Aurobindo Pharma Recent Developments
Table 153. Alembic Pharmaceuticals Company Information
Table 154. Alembic Pharmaceuticals Description and Major Businesses
Table 155. Alembic Pharmaceuticals Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Alembic Pharmaceuticals Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Alembic Pharmaceuticals Recent Developments
Table 158. Alvogen Company Information
Table 159. Alvogen Description and Major Businesses
Table 160. Alvogen Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Alvogen Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Alvogen Recent Developments
Table 163. Torrent Pharmaceuticals Company Information
Table 164. Torrent Pharmaceuticals Description and Major Businesses
Table 165. Torrent Pharmaceuticals Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Torrent Pharmaceuticals Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Torrent Pharmaceuticals Recent Developments
Table 168. Suzhou YUSHI Pharmaceutical Company Information
Table 169. Suzhou YUSHI Pharmaceutical Description and Major Businesses
Table 170. Suzhou YUSHI Pharmaceutical Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Suzhou YUSHI Pharmaceutical Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Suzhou YUSHI Pharmaceutical Recent Developments
Table 173. Changzhou Siyao Pharmaceutical Company Information
Table 174. Changzhou Siyao Pharmaceutical Description and Major Businesses
Table 175. Changzhou Siyao Pharmaceutical Fluoxetine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Changzhou Siyao Pharmaceutical Fluoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Changzhou Siyao Pharmaceutical Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Fluoxetine Distributors List
Table 181. Fluoxetine Customers List
Table 182. Fluoxetine Market Trends
Table 183. Fluoxetine Market Drivers
Table 184. Fluoxetine Market Challenges
Table 185. Fluoxetine Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Fluoxetine Product Picture
Figure 2. Global Fluoxetine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Fluoxetine Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Fluoxetine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Fluoxetine Market Share by Application in 2022 & 2029
Figure 9. Depression
Figure 10. Obsessive–Compulsive Disorder
Figure 11. Panic Disorder
Figure 12. Bulimia Nervosa
Figure 13. Others
Figure 14. Fluoxetine Report Years Considered
Figure 15. Global Fluoxetine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Fluoxetine Revenue 2018-2029 (US$ Million)
Figure 17. Global Fluoxetine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Fluoxetine Revenue Market Share by Region (2018-2029)
Figure 19. Global Fluoxetine Sales 2018-2029 ((K Units)
Figure 20. Global Fluoxetine Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Fluoxetine Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Fluoxetine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Fluoxetine Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Fluoxetine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Fluoxetine Sales YoY (2018-2029) & (K Units)
Figure 26. China Fluoxetine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Fluoxetine Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Fluoxetine Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Fluoxetine Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Fluoxetine Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Fluoxetine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Fluoxetine in the World: Market Share by Fluoxetine Revenue in 2022
Figure 33. Global Fluoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Fluoxetine Sales Market Share by Type (2018-2029)
Figure 35. Global Fluoxetine Revenue Market Share by Type (2018-2029)
Figure 36. Global Fluoxetine Sales Market Share by Application (2018-2029)
Figure 37. Global Fluoxetine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Fluoxetine Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Fluoxetine Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Fluoxetine Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Fluoxetine Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Fluoxetine Revenue Share by Country (2018-2029)
Figure 43. US & Canada Fluoxetine Sales Share by Country (2018-2029)
Figure 44. U.S. Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Fluoxetine Sales Market Share by Type (2018-2029)
Figure 47. Europe Fluoxetine Revenue Market Share by Type (2018-2029)
Figure 48. Europe Fluoxetine Sales Market Share by Application (2018-2029)
Figure 49. Europe Fluoxetine Revenue Market Share by Application (2018-2029)
Figure 50. Europe Fluoxetine Revenue Share by Country (2018-2029)
Figure 51. Europe Fluoxetine Sales Share by Country (2018-2029)
Figure 52. Germany Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 53. France Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 57. China Fluoxetine Sales Market Share by Type (2018-2029)
Figure 58. China Fluoxetine Revenue Market Share by Type (2018-2029)
Figure 59. China Fluoxetine Sales Market Share by Application (2018-2029)
Figure 60. China Fluoxetine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Fluoxetine Sales Market Share by Type (2018-2029)
Figure 62. Asia Fluoxetine Revenue Market Share by Type (2018-2029)
Figure 63. Asia Fluoxetine Sales Market Share by Application (2018-2029)
Figure 64. Asia Fluoxetine Revenue Market Share by Application (2018-2029)
Figure 65. Asia Fluoxetine Revenue Share by Region (2018-2029)
Figure 66. Asia Fluoxetine Sales Share by Region (2018-2029)
Figure 67. Japan Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 71. India Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Fluoxetine Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Fluoxetine Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Fluoxetine Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Fluoxetine Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Fluoxetine Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Fluoxetine Sales Share by Country (2018-2029)
Figure 78. Brazil Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Fluoxetine Revenue (2018-2029) & (US$ Million)
Figure 83. Fluoxetine Value Chain
Figure 84. Fluoxetine Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries